Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07826468

Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery

Sponsor: Hôpital de la Croix-Rousse

View on ClinicalTrials.gov

Summary

Lidocaine is commonly administered through an existing labor epidural catheter to provide surgical anesthesia for urgent cesarean delivery. Lidocaine crosses the placenta, and fetal exposure may be influenced by maternal dose, the interval between epidural administration and delivery, and fetal acid-base status. This prospective multicenter observational cohort study evaluated fetal exposure to lidocaine in women undergoing Lucas category 1 or category 3 cesarean delivery after epidural extension with 2% lidocaine and epinephrine. Lidocaine concentrations were measured in paired umbilical arterial and venous plasma samples collected immediately after delivery. The study compared umbilical cord lidocaine concentrations between the two urgency categories and examined their associations with umbilical pH.

Official title: Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery: the Lidocaine TNT Prospective Multicentre Cohort Study

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

95

Start Date

2025-10-01

Completion Date

2026-09-01

Last Updated

2026-09-22

Healthy Volunteers

No

Interventions

PROCEDURE

Category Lucas 1 cesarian section

Category Lucas 1 cesarian section with the timing of birth \< 15 min

PROCEDURE

Category 3 Lucas Cesarian section

Urgent cesarian section within 60 min

Locations (1)

Hospices Civils de Lyon

Lyon, France